文献速递消化道肿瘤与早癌消化内镜

既往胃镜检查与胃癌患者死亡率:一项匹配回顾性队列研究

Prior gastroscopy and mortality in patients with gastric cancer: a matched retrospective cohort study.
PubMed 文献 · Gastrointest Endosc · 2017-06-23

该研究基于台湾全民健康保险数据库2002至2007年新诊断的20066例胃癌患者,按既往胃镜间隔分为<2年、2-5年和>5年三组并进行匹配。与>5年组相比,<2年组和2-5年组的全因死亡HR分别为0.80和0.83,胃癌特异性死亡HR也显著降低,结论认为诊断前5年内接受过胃镜检查与更低死亡率相关。

要点

  • 胃癌诊断前5年内接受胃镜者全因死亡风险低于5年内未查者。
  • <2年组全因死亡HR 0.80(95%CI 0.72-0.89),2-5年组HR 0.83(95%CI 0.76-0.91)。
  • 作者认为结果可能支持在选定患者中重复内镜或监测内镜的作用。

核心结论

  • 胃癌诊断前5年内接受过胃镜检查的患者死亡率显著更低,作者认为结果可能支持在选定患者中重复内镜或监测内镜的作用。

研究设计与样本

  • 匹配回顾性队列研究,基于台湾全民健康保险数据库2002至2007年新诊断的20066例胃癌患者,排除诊断前6个月内接受胃镜者后按既往胃镜间隔分为<2年、2-5年和>5年三组并进行匹配。

主要发现

  • 匹配后<2年组1286例、2-5年组1286例、>5年组5144例。
  • 与>5年组相比,<2年组全因死亡HR为0.80(95%CI 0.72-0.89;P < .001),2-5年组为0.83(95%CI 0.76-0.91;P < .001)。
  • 与>5年组相比,<2年组胃癌特异性死亡HR为0.80(95%CI 0.71-0.91;P < .001),2-5年组为0.83(95%CI 0.75-0.93;P < .001)。

临床怎么用

  • 作者认为结果可能支持在选定患者中重复内镜或监测内镜的作用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The role of prior gastroscopy on the outcome of patients with gastric cancer remains unknown. This study determines the association between intervals of prior gastroscopy and mortality in patients with gastric cancer. METHODS: We identified 20,066 newly diagnosed patients with gastric cancer in the National Health Insurance Database of Taiwan between 2002 and 2007. After we excluded patients who had gastroscopies performed ≤6 months before the diagnosis of cancer, patients were matched into 3 cohorts according to the intervals of prior gastroscopy: 6 months to 2 years (<2 Y cohort), 2 to 5 years (2-5 Y cohort), and none within the previous 5 years (>5 Y cohort). The 3 cohorts were matched for age, curative treatment for gastric cancer, Helicobacter pylori therapy, and propensity scores comprised of sex, comorbidities, and concomitant medication usage. The primary outcome is the hazard ratio (HR) of all-cause mortality. RESULTS: After matching, we identified 1286, 1286, and 5144 patients for the <2 Y, 2 to 5 Y, and >5 Y cohorts. Compared with the >5 Y cohort, the HR of all-cause mortality for the <2 Y and 2 to 5 Y cohorts was 0.80 (95% confidence interval [CI], 0.72-0.89; P < .001) and 0.83 (95% CI, 0.76-0.91; P < .001), respectively. The HRs of gastric cancer-specific mortality were significantly lower in the <2 Y (0.80; 95% CI, 0.71-0.91; P < .001) and 2 to 5 Y cohorts (0.83; 95% CI, 0.75-0.93; P < .001). CONCLUSIONS: Patients with gastric cancer who had a gastroscopy performed within 5 years before the cancer diagnosis had significantly lower mortality. Our results may support the role of repeat endoscopic examination or surveillance endoscopy in selected patients.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Leung WK, Ho HJ, Lin JT, et al. Prior gastroscopy and mortality in patients with gastric cancer: a matched retrospective cohort study. Gastrointest Endosc. 2017. PMID: 28648576. doi:10.1016/j.gie.2017.06.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。